The Effect of Whole Body Vibration in Individuals With Parkinson's Disease

Status Completed

Clinical Trial Summary

Previous studies reported that whole body vibration has the potential impact on balance and walking abilities in individuals with Parkinson's disease; however, the inconsistent treatment protocols and different experimental designs lead to inconclusive results. Therefore, the purpose of this study is to investigate the short term and long term effect of whole body vibration on sensorimotor function in individuals with Parkinson's disease. The experimental design will be randomized double-blinded controlled trial. Sixty individuals with idiopathic Parkinson's disease will be randomly assigned to two groups and they are non-random whole body vibration group and conventional therapy group. Each participant will receive the treatment about one hour after the administration of medicine. For non-random whole body vibration group, participants will be required to maintain the erect standing position on the vibratory platform and the frequency and amplitude of vibratory stimuli will be 6Hz and 3mm respectively. Each treatment includes five sessions and each session is composed of one minute whole body vibration and one minute rest. For the conventional therapy group, participants will receive the occupational therapy including dynamic balance training and functional ambulatory training. Each session is 10 minutes in both groups and all participants will receive one and twelve treatment sessions for short-term and long-term effect respectively. Outcome measures include proprioceptive sensitivity threshold of upper limb, position sense test of the knee joint, Unified Parkinson's disease rating scale-motor (UPDRS motor), functional reach, and time up and go test (TUG). Specifically, the investigators want to answer the following four questions: 1) Is there any difference in proprioceptive sensitivity, motor performance and balance before and after treatment in individuals with Parkinson's disease? 2) Is there any difference in short-term and long term effect of whole body vibration in individuals with Parkinson's disease? 3) Is there any difference in treatment effect in individuals with Parkinson's disease in Taiwan?

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Parkinson Disease

Clinical Trial Details

NCT number	NCT03777501
Study type	Interventional
Source	Chang Gung University
Contact
Status	Completed
Phase	N/A
Start date	December 28, 2018
Completion date	June 28, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05415774` - Combined Deep Brain Stimulation in Parkinson's Disease	N/A
Recruiting	`NCT04691661` - Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease	Phase 2
Active, not recruiting	`NCT05754086` - A Multidimensional Study on Articulation Deficits in Parkinsons Disease
Completed	`NCT04045925` - Feasibility Study of the Taïso Practice in Parkinson's Disease	N/A
Recruiting	`NCT04194762` - PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation	N/A
Completed	`NCT02705755` - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)	Phase 2
Terminated	`NCT03052712` - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies	N/A
Recruiting	`NCT05830253` - Free-living Monitoring of Parkinson's Disease Using Smart Objects
Recruiting	`NCT03272230` - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System	N/A
Recruiting	`NCT06139965` - Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
Completed	`NCT04580849` - Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease	N/A
Completed	`NCT03980418` - Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam	N/A
Completed	`NCT04477161` - Effect of Ketone Esters in Parkinson's Disease	N/A
Completed	`NCT04942392` - Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic	N/A
Terminated	`NCT03446833` - LFP Beta aDBS Feasibility Study	N/A
Completed	`NCT03497884` - Individualized Precise Localization of rTMS on Primary Motor Area	N/A
Completed	`NCT05538455` - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases	N/A
Recruiting	`NCT04997642` - Parkinson's Disease and Movement Disorders Clinical Database
Completed	`NCT04117737` - A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson	N/A
Recruiting	`NCT03618901` - Rock Steady Boxing vs. Sensory Attention Focused Exercise	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.